Beacon Pharma | The Business Standard
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
THURSDAY, MAY 26, 2022
THURSDAY, MAY 26, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা

Beacon Pharma

Beacon Pharma: Price Sensitive Information
PSI

Beacon Pharma: Price Sensitive Information

Beacon Pharma’s profit up on sales growth
Stocks

Beacon Pharma’s profit up on sales growth

Beacon Pharma may export drugs to Syria
Pharma

Beacon Pharma may export drugs to Syria

Remdesivir pushes up Beacon Pharma’s profit  
Pharma

Remdesivir pushes up Beacon Pharma’s profit  

96% of Covid-19 patients recover in Beacon pharma’s Favipira trial
Covid-19 in Bangladesh

96% of Covid-19 patients recover in Beacon pharma’s Favipira trial

Beacon Pharma MD tests Covid-19 positive
Covid-19 in Bangladesh

Beacon Pharma MD tests Covid-19 positive

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab